January 20, 2023
Lawyers representing a group of Takeda Pharmaceuticals employees are asking for $7.3 million in attorney fees for their work in securing a $22 million settlement with the company to resolve claims that Takeda loaded its 401(k) plan with underperforming and high-cost investment options.
November 15, 2022
Takeda Pharmaceuticals agreed to pay $22 million to resolve a proposed class action accusing the company of loading its 401(k) plan with underperforming and high-cost investment options, according to a filing in Massachusetts federal court.
July 21, 2021
Takeda Pharmaceuticals is likely to come up just short in its effort to dismiss a suit alleging it stocked workers' retirement plans with underperforming funds, a federal judge in Boston said Wednesday.
January 20, 2021
Three former Takeda Pharmaceuticals workers have hit the company with a proposed ERISA class action in Massachusetts federal court, accusing the company of including massively underperforming investment funds in its $1.8 billion employee retirement plan.